NCT06369285 · Interventional trial
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Overall registry status Recruiting
Phase 2
Conditions Hormone Receptor Positive HER-2 Negative Breast Cancer, Metastatic Breast Cancer, Recurrent Breast Cancer
Delaware Valley sites
- Alliance Cancer Specialists · Horsham, PA · Montgomery County · Recruiting
- University of Pennsylvania, Abramson Cancer Center, Perelman Center for Advanced Medicine · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory